Agariblazeispirols A and B, an unprecedented skeleton from the cultured mycelia of the fungus, Agaricus blazei

Tetrahedron Letters

Volumn 44, Issue 43, 2003, Pages 7975-7979

  Hirotani, Masao ^a   Hirotani, Seiko ^a   Takayanagi, Hiroaki ^a   Komiyama, Kanki ^b   Yoshikawa, Takafumi ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO INSTITUTE   (Japan)

Author keywords

18 nor des A ergostane derivative; Agariblazeispirols A and B; Agaricus blazei

Indexed keywords

13BETA,22:22,25 DIEPOXY 5 METHOXY 14BETA METHYL 18 NOR A ERGOSTA 5,7,9,11 TETRAEN 23 OL; ANTIMUTAGENIC AGENT; STEROID; UNCLASSIFIED DRUG;

AGARICUS BLAZEI; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG ISOLATION; DRUG STRUCTURE; FUNGUS CULTURE; LEUKEMIA CELL LINE; MOUSE; MYCELIUM; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PROTON NUCLEAR MAGNETIC RESONANCE; STEREOISOMERISM; STRUCTURE ANALYSIS; X RAY ANALYSIS;

AGARICACEAE; AGARICUS; AGARICUS BLAZEI; FUNGI;

EID: 0141708656     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2003.08.111     Document Type: Article

References (20)

1. Kawagishi H., Inagaki R., Kanao T., Mizuno T., Shimura K., Ito H., Hagiwara T., Nakamura T. Carbohydr Res. 186:1989;267-273.
2. Mizuno T., Hagiwara T., Nakamura T., Ito H., Shimura K., Sumiya T., Asakura A. Agric. Biol. Chem. 54:1990;2889-2896.
3. Ito H., Shimura K., Itoh H., Kawade M. Anticancer Res. 17:1997;277-284.
4. Mizuno M., Morimoto M., Minato K., Tsuchida H. Biosci. Biotechnol. Biochem. 62:1998;434-437.
5. Kawagishi H., Katumi R., Sazawa T., Mizumo T., Hagiwara T., Nakamura T. Phytochemistry. 27:1988;2777-2779.
6. Osaki Y., Kato T., Yamamoto K., Okubo J., Miyazaki K. YAKUGAKU ZASSHI. 114:1994;342-350.
7. Hirotani M., Hirotani S., Takayanagi H., Yoshikawa T. Tetrahedron Lett. 40:1999;329-332.
8. Hirotani M., Hirotani S., Yoshikawa T. Tetrahedron Lett. 41:2000;5107-5110.
9. Hirotani M., Hirotani S., Yoshikawa T. Tetrahedron Lett. 42:2001;5261-5264.
10. Hirotani M., Sai K., Hirotani S., Yoshikawa T. Phytochemistry. 59:2002;571-577.
11. Hirotani M., Sai K., Nagai R., Hirotani S., Takayanagi H., Yoshikawa T. Phytochemistry. 61:2002;589-595.
12. + (6), 299 (50), 225 (76), 211 (38), 202 (47), 199 (36), 149 (44), 28 (100).
13. 3. The absolute configuration was determined by the flack parameter (0.03). Additional crystallographic details, CCDC 210742 (atomic coordinates and equivalent isotopic displacement coefficients) have been deposited at the Cambridge Crystal Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK [fax:+44(0)-1223-336033 or e-mail: deposit@ccdc.cam.ac.uk].
14. 5Br requires C, 66.09; H, 6.41).
15. + (6), 352 (12), 325 (8), 299 (7), 283 (12), 279 (10), 253 (10), 244 (36), 225 (83), 202 (45), 199 (31), 178 (29), 149 (27), 81 (25).
16. Corey E.J., Hong B.-C. J. Am. Chem. Soc. 116:1994;3149-3150.
17. 3N (200 μl). After workup, compound 3 was isolated using HPLC.
18. 3O), 79.9 (C-25), 81.0 (C-22), 109.4 (C-6), 121.0 (C-12), 122.2 (C-10), 122.4 (C-7), 123.9 (C-11), 131.5 (C-9), 139.1 (C-8, C-13), 140.4 (C-17), 155.7 (C-5), 217.6 (C-23).
19. Rho M.-C., Hayashi M., Fukami A., Obata R., Sunazuka T., Tomoda H., Komiyama K., Omura S. J. Antibiot. 53:2000;1201-1206.
20. Altomare A., Burla M.C., Camalli M., Cascarano M., Giacovazzo C., Guagliardi A., Polidori G. J. Appl. Cryst. 27:1994;435-440.